Summary

Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to 2032. Biotech ingredients are structurally similar to naturally occurring compounds and are produced using advanced biotechnological methods such as genetic engineering, recombinant DNA technology, and hybridoma technology. These ingredients are increasingly being adopted in various sectors including personal care, aromatics, and herbal products, significantly contributing to the growth of the biotech ingredients market.

The Global Biotech Ingredients Market is primarily driven by the rising consumer awareness of the adverse effects associated with synthetic products. This shift in consumer preference towards natural and biotech-derived alternatives, particularly in the pharmaceutical and personal care sectors, is fueling the demand for biotech ingredients. Additionally, the increasing utilization of these ingredients in the food and beverage industry is further bolstering market growth. However, the market faces challenges such as the limited availability of raw materials, which could potentially hinder the growth trajectory.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Europe dominated the biotech ingredients market supported by its large consumer base, robust end-use sectors, and favorable governmental policies. Furthermore, the Asia-Pacific region is anticipated to witness the fastest growth during the forecast period, driven by the presence of leading biopharmaceutical companies in countries such as China, India, Japan, and South Korea, along with the region's rich heritage in herbal medicine.

Major market players included in this report are:
Teva Pharmaceutical Industries Ltd.
Mylan, Inc.
Boehringer Ingelheim
Sanofi
AbbVie
Eli Lilly and Company
AstraZeneca plc
Pfizer Inc.
Novartis International AG
Merck & Co.

The detailed segments and sub-segment of the market are explained below:
By Type:
• Active Pharmaceutical Ingredients
• Biosimilars
By Product:
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors
By Expression Systems:
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems
By Region:
North America:
• U.S.
• Canada
Europe:
• UK
• Germany
• France
• Spain
• Italy
• ROE (Rest of Europe)
Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC (Rest of Asia Pacific)
Latin America:
• Brazil
• Mexico
• RoLA (Rest of Latin America)
Middle East & Africa:
• Saudi Arabia
• South Africa
• RoMEA (Rest of Middle East & Africa)
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Global Biotech Ingredients Market Executive Summary
1.1. Global Biotech Ingredients Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Product
1.3.3. By Expression Systems
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biotech Ingredients Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Biotech Ingredients Market Dynamics
3.1. Market Drivers
3.1.1. Rising Consumer Awareness of Harmful Synthetic Products
3.1.2. Increasing Use of Generic Medicines
3.1.3. Growth in Food and Beverage Applications
3.2. Market Challenges
3.2.1. Limited Availability of Raw Materials
3.3. Market Opportunities
3.3.1. Expanding Use in Personal Care Products
3.3.2. Adoption in Emerging Markets

Chapter 4. Global Biotech Ingredients Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biotech Ingredients Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Biotech Ingredients Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Active Pharmaceutical Ingredients
5.2.2. Biosimilars

Chapter 6. Global Biotech Ingredients Market Size & Forecasts by Product 2022-2032
6.1. Segment Dashboard
6.2. Global Biotech Ingredients Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Monoclonal Antibodies
6.2.2. Vaccines
6.2.3. Hormones and Growth Factors
6.2.4. Cytokines
6.2.5. Fusion Proteins
6.2.6. Therapeutic Enzymes
6.2.7. Blood Factors

Chapter 7. Global Biotech Ingredients Market Size & Forecasts by Expression Systems 2022-2032
7.1. Segment Dashboard
7.2. Global Biotech Ingredients Market: Expression Systems Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Mammalian Expression Systems
7.2.2. Microbial Expression Systems
7.2.3. Yeast Expression Systems
7.2.4. Plant Expression Systems
7.2.5. Insect Expression Systems

Chapter 8. Global Biotech Ingredients Market Size & Forecasts by Region 2022-2032
8.1. North America Biotech Ingredients Market
8.1.1. U.S. Biotech Ingredients Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Product breakdown size & forecasts, 2022-2032
8.1.1.3. Expression Systems breakdown size & forecasts, 2022-2032
8.1.2. Canada Biotech Ingredients Market
8.2. Europe Biotech Ingredients Market
8.2.1. UK Biotech Ingredients Market
8.2.2. Germany Biotech Ingredients Market
8.2.3. France Biotech Ingredients Market
8.2.4. Spain Biotech Ingredients Market
8.2.5. Italy Biotech Ingredients Market
8.2.6. Rest of Europe Biotech Ingredients Market
8.3. Asia-Pacific Biotech Ingredients Market
8.3.1. China Biotech Ingredients Market
8.3.2. India Biotech Ingredients Market
8.3.3. Japan Biotech Ingredients Market
8.3.4. Australia Biotech Ingredients Market
8.3.5. South Korea Biotech Ingredients Market
8.3.6. Rest of Asia Pacific Biotech Ingredients Market
8.4. Latin America Biotech Ingredients Market
8.4.1. Brazil Biotech Ingredients Market
8.4.2. Mexico Biotech Ingredients Market
8.4.3. Rest of Latin America Biotech Ingredients Market
8.5. Middle East & Africa Biotech Ingredients Market
8.5.1. Saudi Arabia Biotech Ingredients Market
8.5.2. South Africa Biotech Ingredients Market
8.5.3. Rest of Middle East & Africa Biotech Ingredients Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Teva Pharmaceutical Industries Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Mylan, Inc.
9.3.3. Boehringer Ingelheim
9.3.4. Sanofi
9.3.5. AbbVie
9.3.6. Eli Lilly and Company
9.3.7. AstraZeneca plc
9.3.8. Pfizer Inc.
9.3.9. Novartis International AG
9.3.10. Merck & Co.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes